🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

What if 1 million scRNA-seq libraries can be prepared within $1k? Here we go 👉 21 million cells from 623 mouse tissues, spanning 5 life stages & 3 genotypes, all in a SINGLE study by ONE remarkable student Zehao Zehao Zhang from our lab Rockefeller University! shorturl.at/epsz7

Evaluation of off-label rapamycin use on oral health Matt Kaeberlein. Jonathan An link.springer.com/article/10.100…

📢New Recommended Reading📖in GeroScience Evaluation of off-label rapamycin use on oral health by Johnny Hudson, Tammi Kaeberlein (Tammi Kaeberlein), Matt Kaeberlein (Matt Kaeberlein) & Jonathan Y. An et al. link.springer.com/article/10.100… #sirolimus #oralhealth #healthspan #Rapamune

Great to see more of these large n, well powered studies for aging/longevity! Promising early readouts from the VIBRANT study, testing rapamycin for women's fertility extension: x.com/guardiannews/s…

Guess who funds all the dream come true science (Impetus). Congrats to Zev Williams & Yousin Suh who are making the VIBRANT trial happen!

A bit early for this conclusion, but looking forward to seeing data from this study that Impetus helped fund.

Had a wonderful time at the #ARDD2024 meeting in Copenhagen. We presented the first results from our Impetus funded drug discovery project. My head is full of ideas on how to get this project to the next level! Time to get back to the bench. 🤩🫡

Florian Melerowicz and Jonathan Kölschbach attended the #ARDD2024 conference last week. They came back totally hyped and motivated, full of new ideas and insights, which they shared with the rest of the lab!

The ICCARP is a global consortium working to clinically classify & stage ageing-related pathologies. We have now released a preprint of our first Consensus Statement. Read how we plan to standardise the classification of ageing-related diseases: medrxiv.org/content/10.110…

If you are rich and want to support longevity, Impetus has done a phenomenal job at field building and funding basic research into longevity biotechnology. They're backed by many cool names but could always use more money.

🎉Welcome Dr Robert Huckstepp & Dr Gary Christopher as new coordinators of the Impetus-funded International Consortium to Classify Ageing-Related Pathologies (ICCARP) ... (1/4)

We are thrilled to share that our first paper from my new lab, Spateo (github.com/aristoteleo/sp…) for spatiotemporal modeling of molecular holograms, is now online in Cell: cell.com/cell/fulltext/…. Spateo is a comprehensive analytical framework for 3D whole-embryo spatiotemporal

thanks for funding support from MIT Jameel Clinic for AI & Health, Impetus, CZI Science, Arc Institute 's ignite award and Stanford BASE start-up.

Excited to report that we have discovered a new, endogenous molecular clock in unmodified human cells and tissues. It is ticking away right now in almost every cell in your body. Specifically, in a new paper on BioRxiv, we show that RNA editing by the near-ubiquitous ADAR1 in

What do we know about longevity science? How does everything depend on the exact dosing? Find out what we do & don't know on this week's Inner Cosmos with longevity expert Martin Borch Jensen (Martin Borch Jensen). eagleman.com/podcast/81 #brain #longevity

Exciting mix of biotech tools and systems aging biology, now republished in Science. Norn Group proud to have supported via Impetus, hope for more like it.

1/7 Excited to share our team’s first paper revealing how senescent cells use the GD3 ganglioside as a Senescence Immune Checkpoints (SICs) to bypass immune surveillance published in Nature Aging ! rdcu.be/d4XXJ

📢#callforpaper 📢- #impetusgrants #Impetus focuses on ideas that advance the practical application of #longevityresearch but are unlikely to get funded💰 through traditional grants. Check out their page ➡️(impetusgrants.org) and submit 📩your funded project to